Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

Lithuania’s life sciences sector is preparing to showcase its rapid [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

New England Biolabs (NEB) has introduced the NEBNext Low-bias Small [...]

AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]

New study proposes AI-driven framework to refine gene target discovery [...]